Sunday, September 20, 2026

CBOE Over 15% Up In The Last 24 Hours

ViaNews Editorial Team

October 13, 2023

CBOE Over 15% Up In The Last 24 Hours

(VIANEWS) - CBOE (VIX) has been up by 15.76% for the last session's close. At 17:08 EST on Friday, 13 October, CBOE (VIX) is $19.32.

CBOE Range

Regarding CBOE's daily highs and lows, it's 25.13% up from its trailing 24 hours low of $15.44 and 6.86% up from its trailing 24 hours high of $18.08.

About CBOE's yearly highs and lows, it's 24.4% up from its 52-week low and 44.88% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was a negative 1.15%, a positive 1.12%, and a positive 4.37%, respectively.

CBOE's highest amplitude of average volatility was 3.73% (last week), 4.99% (last month), and 4.37% (last quarter), respectively.

Previous days news about CBOE (VIX)

  • Is cboe global markets (cboe) stock outpacing its finance peers this year?. According to Zacks on Wednesday, 11 October, "Our latest available data shows that CBOE has returned about 28.8% since the start of the calendar year. ", "On average, this group has gained an average of 16.2% so far this year, meaning that CBOE is performing better in terms of year-to-date returns."
  • CBOE (cboe) moves to buy: rationale behind the upgrade. According to Zacks on Wednesday, 11 October, "As such, the Zacks rating upgrade for CBOE is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.", "The upgrade of CBOE to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term."

News about

  • According to DailyForex on Wednesday, 11 October, "In this context, the S&P 500 appears poised for a continued back-and-forth pattern, underscoring the importance of caution and astute risk management.", "In the end, the S&P 500 confronts a pivotal juncture, testing key resistance levels while contending with the reopening of the bond market. "
  • According to MarketWatch on Wednesday, 11 October, "The stock has gained 8% in the year to date, while the S&P 500 has gained 13.5%."
  • According to MarketWatch on Wednesday, 11 October, "Walmart's stock has gained 11% in the year to date, while the S&P 500 SPX has gained 13.5%."
  • According to MarketWatch on Wednesday, 11 October, "His first-hand experience leading through challenges and opportunities of a changing health care services continuum will help accelerate our integrated care strategy at pace." Humana stock has lost 2.3% year to date through Tuesday, while the Health Care Select Sector ETF has declined 3.5% and the S&P 500 has advanced 13.5%."
  • According to MarketWatch on Wednesday, 11 October, "The stock has gained 6.7% in the year to date, while the S&P 500 has gained 13.5%."

More news about CBOE (VIX).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com